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Abstract
Innovative models to facilitate more rapid uptake of research findings into practice are urgently 
needed. Community members who engage in research can accelerate this process by acting as 
adoption agents. We implemented an Evidence Academy conference model bringing together 
researchers, health professionals, advocates, and policy makers across North Carolina to discuss 
high-impact, life-saving study results. The overall goal is to develop dissemination and 
implementation strategies for translating evidence into practice and policy. Each one-day, single-
theme, regional meeting focuses on a leading community-identified health priority. The model 
capitalizes on the power of diverse local networks to encourage broad, common awareness of new 
research findings. Furthermore, it emphasizes critical reflection and active group discussion on 
how to incorporate new evidence within and across organizations, health care systems, and 
communities. During the concluding session, participants are asked to articulate action plans 
relevant to their individual interests, work setting, or area of expertise.
Introduction
New knowledge that affects prevention, clinical care, and health policy is abundant, yet 
timely adoption of research findings into practice remains challenging.1 Educational 
opportunities that expose providers and practitioners to current research findings may 
increase use of evidence-based practices.2 Likewise, opportunities that expose investigators 
to local practice environments may increase production of more relevant research.3 Current 
research dissemination strategies, including professional meetings, continuing medical 
education4, and peer-reviewed publications1 tend to be unidirectional (researcher to 
audience) and fail to address tensions between scientifically rigorous protocols and real-
world application. While knowledge transfer may occur, translation of evidence into practice 
also requires feasible local implementation strategies. We created a low-cost, regional 
conference model to: (1) increase access to research results and evidence-based practices; 
(2) facilitate structured, in-depth discussion among participants; (3) encourage networking 
and collaborations; and (4) engage stakeholders in creating follow-up action plans.
The Evidence Academy Model
A team of academic and community partners led the creation of the “Evidence Academy” 
educational model (Figure 1). An Evidence Academy differs from a conventional 
conference by creating a co-learning experience for a relatively small, well-defined network 
of individuals who represent different sectors but share a collective interest in a specific 
health priority. Evidence Academies have community, clinical, and policy tracks to reach 
participants from different backgrounds and to encourage multilevel engagement.5 We 
increased access by offering scholarships and reduced time and cost by holding the events 
locally. Five Evidence Academies took place from 2010-2012 and were focused on 
colorectal cancer, breast cancer, tobacco and lung cancer, and HIV/AIDS.
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The Evidence Academy Program
State and local committee members jointly planned each conference and participated as 
speakers, moderators, group facilitators, and exhibitors. Multiple factors determined theme 
and locale: (1) health priorities identified by local stakeholders6 and epidemiological 
assessments, with special attention to disparities in disease incidence or outcomes; (2) recent 
study findings with strong implications for clinical and public health practice and policy; (3) 
existing gaps between evidence from clinical trials and actual practice; (4) pre-existing 
partnerships with healthcare and community organizations; and (5) locations with UNC 
regional research staff. Data profiles were created for each conference, which highlighted 
statistics by county or region to illustrate the potential impact of implementing research 
results on a local level.
Each Evidence Academy began with a data-driven overview of the topic followed by 
breakout sessions. Speakers included researchers, practitioners, legislators, advocates, and 
community members affected by the health condition. They highlighted findings from such 
landmark studies as the HIV Prevention Network Trial 0527, the National Lung Screening 
Trial8, and the Carolina Breast Cancer Study.9 Other presenters emphasized making 
informed treatment decisions, promoting evidence-based policy, systems, or environmental 
changes, tailoring evidence-based interventions to address local conditions, and developing 
multi-level partnerships to facilitate the translation of research into practice. Afternoon 
sessions included panel discussions and facilitated small group roundtables where 
participants proposed follow-up activities based on the conference content. These 
discussions incorporated adult learning principles such as critical reflection because 
participants were asked to contemplate how the information was applicable to their own 
work, and what action steps could be taken after the conference.
Evaluation
Process data were collected at each Evidence Academy. Approximately 100 people attended 
each conference, including health professionals (physicians, mid-level providers, specialty 
nurses, RNs), community members, and researchers. An average of 20 counties were 
represented by attendees at each event, indicating broad reach across the state. In post-
conference evaluations, participants indicated on a 1 to 5 scale that the conference content 
was consistent with course objectives (4.57); the content would improve their ability to 
provide appropriate prevention, screening, and treatment services (4.48); and the panel 
discussions helped illustrate practical ways of establishing partnerships across research, 
practice, and care (3.93). When asked how the information would be used, attendees gave 
examples of how they would more effectively counsel clients or patients on tobacco 
cessation (by providing “patient education that smoking causes more than just lung cancer”) 
or HIV testing (by ensuring “we enhance our HIV education and prevention strategies based 
[on]…information provided in today's training”). They remarked on opportunities for 
increased activism (“further advocacy for tobacco free policies and continued funding”) and 
ways to support funding or specific regulations to help address issues affecting their 
communities (“use the youth to advocate as much as possible”).
Rohweder et al. Page 3
J Public Health Manag Pract. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ongoing informal communication with attendees revealed longer-term impacts. We 
observed how the Evidence Academies influenced the adoption of best practices at the 
community level. After the Colorectal Cancer Evidence Academy, an attendee from the state 
primary care association initiated a 50th birthday card intervention at a community health 
center for patients due for colorectal cancer screening. After the Breast Cancer Evidence 
Academy, a regional cancer coalition convened strategic planning meetings and prioritized 
two topics: 1) improving referral systems across county lines and across the cancer care 
continuum and 2) provider education, especially to improve the quality of patient-provider 
interactions in rural, African American communities. The coalition developed a detailed 
resource manual describing patient support resources across several counties and sponsored 
a follow-up conference on improving patient-provider communication.
Next Steps
A limitation of the current Evidence Academy model is the lack of formal long-term 
evaluation to determine exactly how participants incorporated new learning into practice 
over time. For our next conference, we are incorporating an “action learning cohort series”, 
an ongoing forum where local stakeholders will come together to plan and create products 
related to policy, practice, or research. The cohort will receive mentoring, participate in 4-5 
interactive seminars, and work closely with new partners to improve community health.
Conclusion
The Evidence Academies clearly empowered community members to integrate new study 
findings into their daily work, and enabled researchers to connect with and learn from 
attendees. Academic health centers should “be creative in translating and disseminating 
findings and information to the community…and think of dissemination as a cyclical, 
recursive, and dynamic process that … effect(s) change.”3 The Evidence Academy model is 
one strategy to expand the borders of translational research and incorporate community 
partners to achieve better health outcomes.
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Figure 1. The Evidence Academy Logic Model
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